Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

10.99
+0.21001.95%
Volume:494.44K
Turnover:5.38M
Market Cap:577.19M
PE:8.14
High:11.09
Open:10.60
Low:10.54
Close:10.78
52wk High:14.06
52wk Low:4.02
Shares:52.52M
Float Shares:51.26M
Volume Ratio:1.07
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.35
EPS(LYR):-3.5962
ROE:13.92%
ROA:5.27%
PB:0.99
PE(LYR):-3.06

Loading ...

Emergent BioSolutions gets FDA approval of sNDA for Narcan

TIPRANKS
·
Feb 13

FDA Approves Multipack Options for Emergent BioSolutions’ NARCAN Nasal Spray

Reuters
·
Feb 13

Emergent BioSolutions Inc - Multipacks Available Soon Through Narcandirect

THOMSON REUTERS
·
Feb 13

Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

GlobeNewswire
·
Feb 12

Emergent BioSolutions: Will Provide Reporting to Oag for a Period of Three Years

THOMSON REUTERS
·
Jan 16

N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading

Dow Jones
·
Jan 16

Former Emergent BioSolutions CEO sued by NY AG for insider trading

TIPRANKS
·
Jan 16

Emergent BioSolutions outlines transformation and financial guidance at conference

TIPRANKS
·
Jan 15

FDA Approves New Carrying Case for Emergent BioSolutions' OTC NARCAN Nasal Spray

Reuters
·
Jan 14

Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for Narcan® Nasal Spray to Be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness

THOMSON REUTERS
·
Jan 14

H.C. Wainwright Remains a Buy on Emergent Biosolutions (EBS)

TIPRANKS
·
Jan 13

Emergent BioSolutions Announces $100 Million Voluntary Term Loan Prepayment, Reducing Total Debt by 32%

Reuters
·
Jan 12

Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward Its Multi-Year Transformation

THOMSON REUTERS
·
Jan 12

BRIEF-Emergent Bio- Receives $21.5 Mln Order From U.S. Department Of War To Supply Biothrax In 2026

Reuters
·
Jan 09

Emergent BioSolutions Inc - Receives $21.5 Mln Order From U.S. Department of War to Supply Biothrax in 2026

THOMSON REUTERS
·
Jan 09

Emergent BioSolutions Receives $21.5 Million Order to Supply Anthrax Vaccine to U.S. Department of War

Reuters
·
Jan 09

Emergent BioSolutions: Strategic Infectious Disease Positioning and Countermeasure Demand Support Buy Rating and $15 Target

TIPRANKS
·
Jan 08

Emergent BioSolutions Partners with PANTHER to Support Africa CDC-Led Mpox Study

Reuters
·
Jan 08

Emergent BioSolutions and Panther Announce Agreement to Support the Continuation of the Africa Cdc-Led Mpox Study in Africa

THOMSON REUTERS
·
Jan 08

Emergent BioSolutions Inc - Africa Cdc and Panther to Extend Study to Uganda

THOMSON REUTERS
·
Jan 08